Breathe Well Live Well
WAAY |
A new drug can stop asthma attacks
WAAY Imagine struggling to fill your lungs with air and with each breath, feeling like you're suffocating. That's what happens to more than 18-million Americans who suffer from asthma. Medications, shots, inhalers and steroids help most people keep it under … |
View full post on asthma – Google News
|
New asthma drug makes breathing easier
WNDU-TV Imagine struggling to fill your lungs with air and with each breath, feeling like you're suffocating. That's what happens to more than 18-million Americans who suffer from asthma. Medications, shots, inhalers and steroids help most people keep it under … |
View full post on asthma – Google News
KSAT San Antonio |
New Asthma Drug Stops Attacks
KSAT San Antonio ST. LOUIS. (Ivanhoe Newswire) – Imagine struggling to fill your lungs with air and with each breath, feeling like you're suffocating. That's what happens to more than 18-million Americans who suffer from asthma. Medications, shots, inhalers and … |
View full post on asthma – Google News
|
Asthma and COPD Drug Market is expected to reach USD 12619.8 million in 2017
Medgadget.com (blog) According to the new report published by Transparency Market Research “Asthma and COPD Drug Market – Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 – 2017”, the global asthma and COPD market was worth USD … |
View full post on asthma – Google News
The Express Tribune |
Glaxo Asthma Drug Stumbles in Ambitious Heart Patient Study
Bloomberg GlaxoSmithKline Plc's Breo Ellipta medicine didn't extend lives in an ambitious study that sought to show the drug could help patients suffering from both lung and heart troubles. Patients taking the inhaled asthma drug Breo were 12 percent less likely … GSK inhaler trial fails to show longer life Respiratory drug trial failure deals blow to GSK revival plan GSK and Theravance Announce Results From the SUMMIT COPD CV Survival Study |
View full post on asthma – Google News
|
PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023 …
Medgadget.com (blog) The Report PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz. Asthma accounts for … |
View full post on asthma – Google News
|
Ajanta Pharma gets USFDA nod for generic asthma treatment drug
Economic Times NEW DELHI: Drug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules used for prevention and treatment of asthma and to relieve symptoms of seasonal hay fever. The company has … |
View full post on asthma – Google News
Moneycontrol.com |
Cipla rises 4% on asthma drug launch, Kotak says buy
Moneycontrol.com Shares of Cipla surged 4 percent intraday on Thursday on launch of asthma treatment medicine. In partnership with Sandoz, the drug company has launched Pulmicort Respules 1mg /ml version which is used for long-term treatment of asthma and prevention … Cipla surges after its partner Sandoz received USFDA nod for a key drug |
View full post on asthma – Google News
ProPublica |
Elite Runner Had Qualms When Alberto Salazar Told Her to Use Asthma Drug …
ProPublica Elite distance runner Lauren Fleshman says that Salazar helped her get treatment for asthma, but she became squeamish when he suggested that she use medication in a different manner than the doctor instructed. Fleshman, 33, won five NCAA titles while … |
View full post on asthma – Google News
|
Elite Runner Had Qualms When Alberto Salazar Told Her to Use Asthma Drug …
Madison.com Elite distance runner Lauren Fleshman says that Salazar helped her get treatment for asthma, but she became squeamish when he suggested that she use medication in a different manner than the doctor instructed. Fleshman, 33, won five NCAA titles while … |
View full post on asthma – Google News